Company News-QbD Pharmaceutical (Hebei) Co., Ltd.

+86 19991829270

NEWS

Category

Major R&D Milestone Achieved! QbD Pharma Completes Full R&D of Oral GLP-1 Small Molecule Orforglipron API

2026-07-08
Groundbreaking Process Optimization | QbD Pharma’s Theobromine API Achieves Unmatched Global Cost Advantage, Consistent Purity ≥99.0%

2026-07-06
Good News! QbD Pharmaceutical Secures Four Clinical Urgent Injection Approvals, Completing Its Electrolyte Emergency “Golden Combination”

2026-04-17
QbD Pharma 2025 Outstanding Employees Recognition

2026-02-14
QbD Pharma 2025 Year in Review

2026-02-11
QbD Pharma Partners with Hebei University of Science and Technology to Establish Joint Laboratory

2026-01-09
The inauguration ceremony of the QbD Pharma preparation workshop was successfully held on September 9, 2025 in Cangzhou, Hebei, China

2025-09-09
QbD Pharmaceutical's High-end Injection Base Grandly Completed,

2025-09-09
Unleashing Pharmaceutical Excellence at CPHI China

2025-05-07
绪必迪药业祝您春节快乐QbD Pharma Wish you a happy Chinese New Year

2025-01-29
绪必迪药业2025年度总结大会 Year -End Summary Conference 2025 QbD Pharma

2025-01-18
Merry Christmas ！

Merry Christmas

2024-12-24

1
2
›

Practise Technical Combination; Put forward the Transformation of Medical Technology Achievement

COMPANY

FAQ

SHIPPING

RETURNS

ORDER STATUS

GIFT CARD BALANCE

ACCESSIBILITY

USEFUL

MY ACCOUNT

CHECKOUT

VALIDATION

WISHLIST

TERMS OF USE

FAQ

NEWSLETTER

Lorem ipsum dolor sit amet, consectet adipi elit, sed do eius tempor.

Copyright © 2023-2033 QbD Pharmaceutical (Hebei) Co., Ltd. All Rights Reserved. technical support：xdnet